D. A. Hay

发表

In Vitro and In Vivo Activity of a Novel Series of Radical Trapping Agents in Model Systems of CNS Oxidative Damage

J. Carney, Craig E. Thomas, A. Carr, 1994, Annals of the New York Academy of Sciences.

A highly convergent synthesis of benzimidazolylpiperidines

J. Kane, D. A. Hay, M. Staeger, 1990 .

Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors

Richard E. Moore, M. Martinelli, C. Shih, 2005, Investigational New Drugs.

Resolution of cis-4-O-TBS-2-Cyclopenten-1,4-diol

T. Curran, D. A. Hay, 1996 .

The preparation of optically active 2-cyclopenten-1,4-diol derivatives from furfuryl alcohol

C. Koegel, T. Curran, D. A. Hay, 1997 .

Characterization of the Radical Trapping Activity of a Novel Series of Cyclic Nitrone Spin Traps (*)

Craig E. Thomas, R. Bernotas, Roy Vaz, 1996, The Journal of Biological Chemistry.

Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region).

M. Martinelli, R. Schultz, C. Shih, 1999, Bioorganic & medicinal chemistry letters.

Optimized Catalytic Enantioselective Aryl Transfer Process Gives Access to mGlu2 Receptor Potentiators

Michael E. Laurila, Bruce W. Shaw, Michael A. Staszak, 2007 .

Synthesis and Radical Scavenging Activity of 3,3-Dialkyl-3,4- dihydroisoquinoline 2-Oxides.

Craig E. Thomas, R. Bernotas, A. Carr, 1996 .

Synthesis and radical scavenging activity of 3,3-dialkyl-3,4-dihydro-isoquinoline 2-oxides

Craig E. Thomas, R. Bernotas, A. Carr, 1996 .

Design, Development, and Scale-Up of a Selective meso-Epoxide Desymmetrization Process

David D. Anderson, Mindy B. Forst, Richard D. Miller, 2007 .

Development of the Carbocyclic Nucleoside MDL 201449A: A Tumor Necrosis Factor-α Inhibitor

Timothy J. N. Watson, M. Webster, T. Curran, 1998 .